Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PFE crawled time : 02:00 save search
Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-01-31 (Crawled : 02:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.56%
H: 1.25%
C: -0.33%
keytruda drug japan bladder cancer treatment application advanced
Global Obesity Treatment Market Poised to Reach $26.44 Billion by 2028, Fueled by Rising Prevalence and Innovative Interventions
Published: 2023-08-25 (Crawled : 02:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.06%
H: 1.52%
C: 0.66%
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.34%
H: 1.29%
C: 0.93%
MDT | News | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: -0.98%
H: 1.19%
C: 0.82%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
obesity reach treatment global market
Global Axial Spondyloarthritis Treatment Market to 2027: Increase in the Number of Approved Biosimilars Fuels the Sector
Published: 2023-06-16 (Crawled : 02:00) - prnewswire.com
UCBJY | $64.07 -4.38% 72K
|
Manufacturing
|
| O: 1.21%
H: 0.0%
C: -0.2%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.28%
H: 1.25%
C: 0.5%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.46%
H: 0.31%
C: -0.15%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.41%
H: 0.26%
C: -1.77%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.32%
H: 2.1%
C: 1.97%
approved treatment global market
Stomach Cancer Treatment Market Report 2023: Growing Demand for Painless Low-Cost Treatment and Favorable Reimbursement Scenarios Bolsters Sector
Published: 2023-04-14 (Crawled : 02:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.08%
H: 0.49%
C: -0.76%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.24%
H: 0.55%
C: 0.13%
report favorable cancer treatment growing market
Macular Degeneration Treatment Market to Surpass US$ 21.1 Bn by 2031: TMR Study
Published: 2022-09-21 (Crawled : 02:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: -1.99%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.09%
H: 0.38%
C: -1.99%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.73%
H: 0.04%
C: -1.85%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: -0.47%
H: 1.24%
C: -2.32%
treatment macular study market
CureDuchenne Hosts Webinar on COVID-19 Vaccines to Educate Duchenne Community, Alongside Clinical, Scientific and Regulatory Experts
Published: 2021-03-19 (Crawled : 02:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.06%
H: 0.2%
C: -0.62%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.14%
H: 0.5%
C: -0.4%
covid vaccine duchenne
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.